tlx250,nivolumab,girentuximab
bms,esteve,prometheus,telix pharmaceuticals,heidelberg pharmaceuticals
['nivolumab', 'starlite-2', 'renal,(-adrenal)', 'starlite2', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'nivo', 'girentuximab', 'imab ']
#starlite2 phase 2 study of nivolumab + 177lutetium-labeled anti carbonic anhydrase ix monoclonal antibody girentuximab (177lu-girentuximab) in pts with advanced clear cell #renalcellcarcinoma. presented by . #gu23 &gt; 
Largest global online community of #urological medical professionals & patients. #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology